Levetiracetam | m-entrepreneurship.com

Product Name :
Levetiracetam

Search keywords :
Levetiracetam

drugId :
null

Target Vo:
Synaptic vesicle glycoprotein 2A

Target Vo Short Name :
SV2A

Moa_Name:
Synaptic vesicle glycoprotein 2A modulators

First Approval Country :
United States

First Approval Date Filter:
1999

Origin Company_Name :
Ucb Sa

Active Company_Name :
Agenebio Inc

Active Indication_Name:
Epilepsies, Partial

In Active Indication_Name:
Opioid-Related Disorders

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Crovalimab medchemexpress
Glembatumumab ADC Antibody
Dopamine Transporter Antibody: Dopamine Transporter Antibody is an unconjugated, approximately 68 kDa, rabbit-derived, anti-Dopamine Transporter polyclonal antibody. Dopamine Transporter Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, rat, and predicted: dog, cow background without labeling.

Author: Betaine hydrochloride

Related Posts